What is known and objective: Despite the numerous studies investigating drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN), the understanding and quantitative data in developing countries remain limited. The study aimed to describe and quantify the drug-related risk of SJS/TEN in a resource-limited context using the Vietnamese spontaneous reporting database (VSRD) of adverse drug reactions.
| WHAT IS K NOWN AND OBJEC TIVE
Cutaneous disorders are conspicuous immune-mediated reactions and a common feature (in 10%-30%) of adverse drug reactions (ADRs) as the skin is the largest organ in the body and clinical signs can easily be detected. 1, 2 Characterized by severe, albeit rare mucocutaneous blisters and with a mortality rate ranging from 1% to 40%, the detection, monitoring, management and prevention of StevensJohnson Syndrome and Toxic Epidermal Necrolysis (SJS/TEN) pose a significant public health issue. 3, 4 Although the pathogenesis of drug-induced SJS/TEN is not fully understood, these disorders are thought to be related to dysfunctions of the immune system, as well as genetic factors such as HLA alleles. 5, 6 Over the last decade, knowledge about drug-induced SJS/TEN has improved, but questions nevertheless remain unanswered, including the debate on paracetamol and meloxicam signals in the United States and Europe. 4, 7 In addition, quantitative information on drug-induced SJS/TEN in developing countries is sparse, and the impact of the social pharmacology context on this area of research has not been fully elucidated.
8,9
Due to genetic variations, the difference in geographical areas, disease patterns, health systems, drug utilization and specific features of the pharmacovigilance systems, caution should be exercised when interpreting SJS/TEN findings from one country to the next.
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Therefore, risk evaluation should be considered as a separate national issue in the context of SJS/TEN, and regional-based research is required to identify the risk in a typical situation.
Conversely, easily identifiable ADRs involving the skin and appendages are more common in new pharmacovigilance systems, especially in a developing context, and every emerging system always begins by attempting to analyse them. 11 In addition, given the rare incidence rate of about 1-6 cases/1 000 000 people per year 12 , analysis using an ADR reporting source is always one of the most appropriate methods for significantly, year-on-year, reaching an annual rate of 118 reports/ million persons in 2016. 13, 14 The use of cumulative ADR reporting in the database is necessary to summarize salient information and subsequently propose appropriate guidelines for rational drug use.
Disproportionality analysis is commonly used to detect drug safety signals from spontaneous reporting databases. 15 The subgroup approach to this method was developed using a subset database relating to relevant pharmacological groups or patients. [16] [17] [18] However, to the best of our knowledge, subgroup analysis using the ADR-grouping approach (eg according to SOC-System Organ Classification) has not been used to analyse specific adverse drug reactions such as SJS/TEN. Therefore, to assess the risk in developing countries, this study was carried out using the Vietnamese spontaneous reporting database (VSRD) in order to describe the overall profile of drug-induced SJS/TEN in the context of a resource-limited country and to apply subgrouped disproportionality analysis to generate signals of severe, drug-induced ADRs in the Vietnamese population.
| ME THODS
To be validated and recorded in the national ADR reporting database, every ADR report submitted to NDIADRMC had to be recorded on an official ADR form including the following essential information: patient's characteristic, suspected drugs, description of the ADR and the reporter's details. 13 All ADR reports were then reviewed, and causality was assessed (using the World Health Organization-Uppsala Monitoring Nikolsky's sign and at least one case of mucous involvement (genital, eyes, mouth, etc.).
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| Statistical analysis
We where Y is the reporting year, G is gender and A is the patient's age in the ADR reports. A significant positive safety signal is generated with one specific drug if it meets two criteria: minimum of three SJS/TEN cases relating to this drug and the lower limit of the 95% CI of the ROR relating to this drug >1. were identified. According to the data presented in Table 1 , the number of spontaneous reports of cutaneous ADRs or MLOSCARs increased annually, whereas the drug-induced SJS/TEN trend fluctuated. We found a significant difference between the two groups in terms of age, severity, reporter, outcome and TTO. Male patients accounted for 59%
| RE SULTS AND D ISCUSS I ON
of SJS/TEN cases and 51% of other MLOSCAR cases (P = 0.166). SJS/ TEN patients were older than noncase patients, with mean ages of 42.5 (±22.9) and 37.7 (±21.4), respectively (P = 0.023).
Doctors were the main healthcare practitioners (HCPs) to report SJS/TEN cases (n = 72, 53.3%) followed by pharmacists (n = 34, 25.2%). In terms of history of allergy in the MLOSCAR reports, 107 patients (3.6%) experienced a previous allergy with the suspected drug or the same pharmacological group in which four patients (2.9%) developed SJS/TEN after readministration of the same drug.
The recovery rate in SJS/TEN patients was worse than in the noncase context (9.6% not recovered and 25% recovering compared to 2.3% not recovered and 17.9% recovering at the time of reporting).
About half of SJS/TEN cases were life-threatening (Grade 4; n = 61, (Table 3) . Carbamazepine (n = 25) followed by allopurinol (n = 15) was the most widely reported drugs in relation to SJS/TEN, and the signals for these drugs were robust and reliable with the detection of a single suspected drug in 80% cases. On the contrary, although signals were also generated for paracetamol, cefixime, valproic acid and meloxicam, the cases with concomitant medication were far more prevalent, accounting for up to 77%. It was also noted that SJS/TEN induced by paracetamol, meloxicam and antibiotics, including cefixime, occurred significantly compared to other drugs (latency of mainly 2-3 days compared to 1-3 weeks). induced SJS/TEN, we also found that doses of allopurinol were higher than recommended in three patients (20%), allopurinol was used for hyperuricemia without symptoms of gout (inconsistent with the current summary of product characteristics in Vietnam)
| D ISCUSS I ON
in five patients (33.3%), and was used without prescription in one patient. Therefore, prompt action should be taken to restrict such irrational use of this drug to minimize the risk of allopurinol-induced SJS/TEN. On the other hand, signals relating to sulfamethoxazole/trimethoprim-a well-known cause of SJS/TEN in many studies-were also generated in our study. 4, 24, 25, 37 The risk of paracetamol-induced SJS/TEN was recently discussed in studies using spontaneous reporting data (Japan, United States). 7, 38 In 2013, the US FDA issued a public announcement of rare but serious drug-related reactions containing paracetamol. Similarly, in 2014, the Drug Administration of Vietnam also made an official announcement requesting that the risk of severe cutaneous reactions be updated on the packaging labels of all registered products containing paracetamol in Vietnam. 39, 40 However, EuroSCAR and the French studies viewed paracetamol as a confounding factor.
4,41
Despite the exclusion of cases with delayed onset of <1 day in our study and the ubiquitous use of paracetamol in the Vietnamese population, paracetamol still generated a significant signal. We also found that meloxicam (significantly discordant results between European and U.S. studies) generated the safety risk. However, these results require cautious interpretation to avoid bias because more common concomitant medications and the TTOs of these drugs were relatively shorter than other suspected drugs (in the ALDEN scale, the evidence level with drugs whose TTOs range from 5 to 28 days is higher than those with TTOs ranging from 1 to 4 days).
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Our finding was in accordance with results from China or SouthEast Asian countries in which carbamazepine, allopurinol and antibiotics were the most commonly implicated drugs to cause SJS/ TEN. 27, 42 However, among antibiotic-induced SJS/TEN, the thirdgeneration cephalosporins were the most reported in our study instead of penicillins as the predominant group in those studies. In fact, the tendency of overuse of antibiotics in Vietnam, especially third-generation cephalosporins, is an important health issue in the country and greatly influences the structure of drug-induced MLOSCAR. 43, 44 In contrast to the negative signal of other cephalosporins, the cefixime-generated risk was clearly apparent in our studies. One notable point is that antituberculosis drugs were mentioned in many SJS/TEN reports, but no signals were generated in relation to these drugs. This could be attributed to the popularity of these drugs in other MLOSCAR reports because of the integration of the public health programme in the pharmacovigilance system. countries where traditional and herbal medicines are relatively popular. 8 The causal relationship is both complex and challenging given the cocktail of herbs frequently used in THM products. In addition, the problem is exacerbated by little or no labelling information and information missing from spontaneous reports. Therefore, an enhanced reporting system and additional research are warranted to provide accurate safety alerts when using this type of medication.
In addition, positive signals were generated and well documented in relation to colchicine and valproic acid. 4 Nevertheless, the number of cases relating to these drugs is still too low to acknowledge this as a risk in Vietnam, and further follow-up and monitoring are required.
Many studies report female predominance, which is regarded as a risk factor. 4, 38, [45] [46] [47] [48] However, the reason why severe adverse reactions (especially SJS/TEN) are more common among women has not been elucidated to date. 8 Our population-based study also
shows that male patients were more likely to suffer SJS/TEN than their female counterparts-a marked difference compared to earlier studies of other population. Our results show that SJS/TEN occurs at all ages but is mainly concentrated in the 18-65 year age bracket (mean age 42.5 ± 22.9 years). From the social pharmacology perspective, the fact that SJS/TEN patients were younger than other study cohorts could be partly explained by differences in social and health insurance coverage and the characteristics of drug use.
One notable finding in our study was that five SJS/TEN cases (3.7%) and 152 other MLOSCAR cases (4.5%) also reported patients with a history of allergy to the suspected drug or a drug in same suspected pharmacological group. This suggests that patients with a history of hypersensitivity to one drug may also be at increased risk of allergy to other drugs. 49 Therefore, caution should be exercised when prescribing drugs for patients with a history of allergy and re-exposure to the causative agents should be avoided. A patient's allergy history should be carefully reviewed prior to treatment, especially in the complex situation in Vietnam.
The use of the MLOSCAR subgroup approach in a cumulative spontaneous reporting database to evaluate drug-induced SJS/TEN is, to our knowledge, a first in terms of disproportionality analysis.
Our selection criteria focusing on MLOSCAR and SJS/TEN with a minimum TTO of 1 day offer some advantages: (a) shared risk factors for cases and noncases, severe cutaneous reactions, similar TTO; (b) considerable reduction in the number of noncases and an increased case/noncase ratio compared to the standard case/noncase method (limitation of the prescription bias); and (c) limitation of non-case-related selection bias by eliminating all ADRs manifested through skin tests and cutaneous symptoms in anaphylactic shock/reactions. 50, 51 As this research is based on the spontaneous ADR reporting system, limitations from the database per se are inevitable, including recall bias or classification bias. 52 Given the under-reporting issue, whereby case/noncase results generate only safety signals, further studies are required to confirm these hypotheses. In addition, report quality issues, such as lack of information coupled with incomplete or inaccurate information, also make it difficult to identify and assess ADR-drug causal relationships, especially with these sophisticated or complex ADR reports in a limited-resource context. Furthermore, the TTOs of signal-generating drugs (paracetamol, meloxicam and cefixime) were small (within 1-2 days), suggesting bias could not be eliminated.
| WHAT IS NE W AND CON CLUS I ON
This study was the first evaluation of drug-induced SJS/TEN using the case/noncase method based on a spontaneous reporting database with the specific characteristics of a developing healthcare system. Besides, well-known signals for allopurinol, carbamazepine and sulfamethoxazole/trimethoprim, and despite the limitations of our study, we also identified signals relating to paracetamol and meloxicam following inconsistencies in European and U.S. studies focusing on these drugs. In terms of signals generated specifically for the Vietnamese population, the capacity of a new pharmacovigilance system to generate drug safety signals was verified. These results can also contribute to the understanding of drug-induced SJS/ TEN around the globe. However, further epidemiological and systematic studies are required to verify these signals in Vietnam and validate the new subgrouped case/noncase approach. 
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